Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Povorcitinib Tablets for Nonsegmental Vitiligo
Official title: A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo
Status: Closed to new participants
Description:
This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.
Phase: Phase 3.
What is being studied: Drug: Povorcitinib; Drug: Placebo.
Who can take part: ages 18 Years, 467 participants planned.
Enrollment status: Closed to enrollment. The study starts 29 November 2023 and expected to finish 24 February 2027.
Source: ClinicalTrials.gov, NCT06113445 (https://clinicaltrials.gov/study/NCT06113445).
Start date: November 29, 2023
Completion date: February 24, 2027
Organizer: Incyte Corporation
Link: https://clinicaltrials.gov/study/NCT06113445
The registry does not list a contact for this study. Use the link above to reach the study record on ClinicalTrials.gov.
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Is vitiligo contagious?
Vitiligo is not contagious. This means it cannot be spread from person to person through physical contact, sharing personal items, or any other means of transmission. Vitiligo i...
- Can a gluten-free diet help with vitiligo?
It's very unlikely. We have specifically looked into claims that gluten-free diet may ease symptoms of vitiligo, or completely reverse it, and found no firm scientific evidence ...
- Is there a traditional medicine to treat vitiligo?
Traditional remedies can be helpful for managing stress or general metabolic health, but when it comes to vitiligo, the evidence is limited. While some natural supplements provi...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.